Comparison of cellular and humoral immune responses induced by primary, consensus or mosaic HIV-1 Env DNA vaccines by Yan J, Pankhong P, Khan AS, Sardesai NY, Weiner DB

OA05-02. Analysis of DNA compared to Ad5 vaccination, as single and mixed modalities, demonstrates robust induction of cellular immune responses in macaques by Sardesai NY, Betts MR, Shiver J, Casimiro D, Finnefrock A, Khan AS, Satishchandran A, Wu L, Hirao LA, Weiner DB

Potent cellular immune responses after therapeutic immunization of HIV-positive patients with the PENNVAX®-B DNA vaccine in a Phase I Trial by Tebas P, Ramirez L, Morrow MP, Yan J, Shah D, Lee J, Weiner DB, Boyer J, Bagarazzi M, Sardesai NY

Minimally invasive and surface electroporation delivery of DNA vaccines for the induction of robust humoral immune responses against HIV antigens by Sardesai NY, Khan AS, McCoy J, Lin F, Mendoza JM, Yang M, Yan J, Hutnick N, Muthumani K, Weiner DB, Broderick KE

DNA vaccines expressing conserved elements provide potent and broad immune responses by Pavlakis GN, Kulkarni V, Valentin A, Rosati M, Sardesai NY, Mothe B, Brander C, LeGall S, Weiner DB, Rolland M, Mullins JI, Felber BK

P03-11. DNA vaccination with IL-12 lowers viral replication following SIVmac251 challenge by Boyer JD, Sardesai NY, Betts MR, Miller N, Watkins D, O'Connor D, Wiseman R, Lank S, Karl J, Dai A, Khan AS, Wu L, Hirao LA, Weiner DB